These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 32909168

  • 41. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
    Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Wu H.
    World J Gastroenterol; 2008 Aug 07; 14(29):4627-32. PubMed ID: 18698676
    [Abstract] [Full Text] [Related]

  • 42. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, Israel O.
    J Nucl Med; 2004 Oct 07; 45(10):1640-6. PubMed ID: 15471827
    [Abstract] [Full Text] [Related]

  • 43. Utility of FDG PET-CT in CT Stage IA non-small cell lung cancer: The New Zealand Te Whatu Ora Northern region experience.
    Kelly RJ, Anderson GD, Joshi BS, Donald JJ.
    J Med Imaging Radiat Oncol; 2024 Sep 07; 68(6):645-650. PubMed ID: 38941179
    [Abstract] [Full Text] [Related]

  • 44. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep 07; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 45. Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT.
    Jiménez-Bonilla JF, Quirce R, Martínez-Rodríguez I, Banzo I, Rubio-Vassallo AS, Del Castillo-Matos R, Ortega-Nava F, Martínez-Amador N, Ibáñez-Bravo S, Carril JM.
    Lung Cancer; 2013 Jul 07; 81(1):71-6. PubMed ID: 23597930
    [Abstract] [Full Text] [Related]

  • 46. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb 07; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 47. Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
    Schaarschmidt BM, Grueneisen J, Metzenmacher M, Gomez B, Gauler T, Roesel C, Heusch P, Ruhlmann V, Umutlu L, Antoch G, Buchbender C.
    Eur Radiol; 2017 Feb 07; 27(2):681-688. PubMed ID: 27180186
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
    Brocken P, van der Heijden HF, Dekhuijzen PN, Peters-Bax L, de Geus-Oei LF.
    Respiration; 2014 Feb 07; 87(1):32-7. PubMed ID: 23595051
    [Abstract] [Full Text] [Related]

  • 53. The value of different 18F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients.
    Anwar H, Vogl TJ, Abougabal MA, Grünwald F, Kleine P, Elrefaie S, Nour-Eldin NA.
    Ann Nucl Med; 2018 Dec 07; 32(10):687-694. PubMed ID: 30219989
    [Abstract] [Full Text] [Related]

  • 54. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
    Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.
    Nucl Med Commun; 2011 Dec 02; 32(12):1162-8. PubMed ID: 21946617
    [Abstract] [Full Text] [Related]

  • 57. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 02; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 58. 18F-FDG PET/Contrast-Enhanced CT for Initial Staging and Strategic Treatment of Non-Small Cell Lung Cancer: A Prospective Study.
    Promteangtrong C, Kunawudhi A, Phadungrerk R, Iamsa-art C, Chotipanich C.
    J Med Assoc Thai; 2015 Oct 02; 98(10):1010-8. PubMed ID: 26638593
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.